CB1093, a novel vitamin D analog; Effects on differentiation and clonal growth on HL-60 and de novo leukemia cells

Leukemia Research

Volumn 21, Issue 4, 1997, Pages 321-326

  Pakkala, Ilkka ^a   Savli, Hakan ^a   Knuutila, Sakari ^a   Binderup, Lise ^b   Pakkala, Seppo ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b LEO PHARMA A S   (Denmark)

Author keywords

AML; Differentiation; HL 60; Proliferation; Vitamin D analogs

Indexed keywords

CALCIUM; SEOCALCITOL; VITAMIN D DERIVATIVE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CALCIUM BLOOD LEVEL; CELL GROWTH; CELL STRAIN HL 60; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CALCITRIOL; CELL DIFFERENTIATION; CELL DIVISION; CLONE CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; HL-60 CELLS; HUMANS; LEUKEMIA; RATS; TUMOR CELLS, CULTURED;

EID: 0030946668     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00131-2     Document Type: Article

References (15)

1. Berman, E., Heller, G., Santorsa, J., Mckenzie, S., Gee, T., Kempin, S., Gulati, S., Andreeff, M., Kolitz, J., Gabrilove, J., Reich, L., Mayer, K., Keefe, D., Trainor, K., Schluger, A., Penenberg, D., Raymond, V., O'Reilly, R., Jhanwar, S., Young, C. & Clarkson, B. Results of a randomised trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. Blood, 1991, 77, 1660-1674.
2. Phillips, G., Reece, D., Shepherd, J., Barnett, M., Brown, R., Frei-Lahr, D., Klingemann, H., Bolwell, B., Spinelli, J., Herzig, R. & Herzig, G. High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults. Blood, 1991, 77, 1429-1435.
3. Zittoun, R., Jehn, U., Fiere, D., Haanen, C., Löwenberg, B., Willemze, R., Abets, J., Bury, J., Peetermans, M., Hayat, M., Suciu, S., Solbu, G. & Stryckmans, P. Alternating v repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC leukemia co-operative group. Blood, 1989, 73, 896-906.
4. Koeffler, H. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood, 1983, 62, 709-721.
5. Huang, M., Ye, Y., Chen, S., Chai, J., Lu, J., Zhoa, L., Gu, L. & Wang, Z. Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 1988, 72, 567-572.
6. Castaigne, S., Chomienne, C., Daniel, M., Ballerini, P., Berger, R., Fenaux, P. & Degos, L. All-trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood, 1990, 76, 1704-1709.
7. Chen, Z., Xue, Y., Zhang, R., Tao, R., Xia, X., Li, C., Wang, W., Zu, W., Yao, X. & Ling, B. A clinical and experimental study on all-trans-retinoic acid-treated acute promyelocytic leukemia patients. Blood, 1991, 78, 1413-1419.
8. Warrell, R. J., Frankell, S., Miller, W., Scheinberg, D., Itri, L., Hittelman, W., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., Gabrilove, J., Gordon, M. & Dmitrinovsky, E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). New England Journal of Medicine, 1991, 324, 1385-1393.
9. Zhou, J., Norman, A., Chen, D., Sun, G., Uskokovic, M. & Koeffler, H. l,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice. Proceedings of the National Academy of Sciences, U.S.A., 1990, 87, 3929-3932.
10. Honma, Y., Hozumi, M., Abe, E., Konno, K., Fukushima, M., Hata, S., Nishii, Y., DeLuca, H. & Suda, T. 1,25-dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolongs survival time of mice inoculated with myeloid leukemia cells. Proceedings of the National Academy of Sciences, U.S.A., 1983, 80, 201-204.
11. Koeffler, H., Hirji, K. & Itri, L. Group SCL. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treatment Report, 1985, 69, 1399-1407.
12. Collins, S., Gallo, R. & Gallagher, R. Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature, 1977, 270, 347-349.
13. Collins, S. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood, 1987, 70, 1233-1244.
14. Pakkala, S., de Vos, S., Elstner, E., Rude, R., Uskokovic, M., Binderup, L. & Koeffler, H. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels. Leukemia Research, 1995, 19, 65-72.
15. Zhou, J., Norman, A., Lubbert, M., Collins, E., Uskokovic, M. & Koeffler, H. Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone calcium mobilization. Blood, 1989, 74, 82-93.